Radiation Oncology

Doç. Dr. Hilal Alkış

Doctor and researcher Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyRadiation Oncologysaglik.gov.trFrom source
  • InstitutionMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Publications49 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0003-4722-0724ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1393413/doktorlarimiz.html#hilal-alkissaglik.gov.tr

Scientific work

Publications

49 publications

  1. The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy

    Medicina, 2025

    DOI 10.3390/medicina61081449 PMID 40870493 1 citation (Europe PMC) Open-access full textSource: ORCID

  2. Inflammatory Biomarkers and LIPI Score to Predict Treatment Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy

    RADIOTHERAPY AND ONCOLOGY, 2025

    Source: ORCID

  3. Predicting Survival in Pancreatic Cancer: Insights from Systemic Inflammatory Scores

    RADIOTHERAPY AND ONCOLOGY, 2025

    Source: ORCID

  4. Value of Systemic Inflammatory Markers to Predict Treatment Response in Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation

    RADIOTHERAPY AND ONCOLOGY, 2025

    Source: ORCID

  5. 3951 Predicting Survival in Pancreatic Cancer: Insights from Systemic Inflammatory Scores

    Radiotherapy and Oncology, 2025

    DOI 10.1016/s0167-8140(25)03036-1 Source: OpenAlex

  6. 3950 Value of Systemic Inflammatory Markers to Predict Treatment Response in Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation

    Radiotherapy and Oncology, 2025

    DOI 10.1016/s0167-8140(25)03035-x Source: OpenAlex

  7. 2959 Inflammatory Biomarkers and LIPI Score to Predict Treatment Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy

    Radiotherapy and Oncology, 2025

    DOI 10.1016/s0167-8140(25)01396-9 Source: OpenAlex

  8. SARCOMAS

    Turkiye Klinikleri eBooks, 2024

    DOI 10.5336/978-625-395-393-5_p83 Source: OpenAlex

  9. PO-2084 Prediction of hormone status in breast cancer using 18F-FDG PET/CT radiomics features

    Radiotherapy and Oncology, 2023

    DOI 10.1016/s0167-8140(23)66999-3 Source: OpenAlex

  10. Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy

    Cureus, 2023

    DOI 10.7759/cureus.40548 PMID 37465788 3 citations (Europe PMC) Open-access full textSource: ORCID

View all 49 publications